
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW ON: NOVEL DRUG DELIVERY TECHNOLOGY OF PEGFILGRASTIM
Siti Malahayati*, Mia Audina, Ferry Suhariyanto, Nuning Farida
Abstract Pegfilgrastim is used to treat patients who are undergoing chemotherapy, in the case of neuropenia can reduce the incidence of infection. Pegfilgrastim is a longer acting form of filgrastim and the manufacturer recommends that it should not be administered within 14 days before chemotherapy. This review article focuses on drug delivery technology of Pegfilgrastim (production and formulation). Filgrastim in combination with PEG formula Filgrastim (being Pegfilgrastim) will further improve the stimulator of GCF. Keywords: Pegfilgrastim, Filgrastim, Anti-cancer, Production, Formulation. [Full Text Article] [Download Certificate] |
